Your browser doesn't support javascript.
loading
TP53-related signature for predicting prognosis and tumor microenvironment characteristics in bladder cancer: A multi-omics study.
Tao, Yuting; Li, Xia; Zhang, Yushan; He, Liangyu; Lu, Qinchen; Wang, Yaobang; Pan, Lixin; Wang, Zhenxing; Feng, Chao; Xie, Yuanliang; Lai, Zhiyong; Li, Tianyu; Tang, Zhong; Wang, Qiuyan; Wang, Xi.
Afiliação
  • Tao Y; Department of Biochemistry and Molecular Biology, School of Basic Medicine, Guangxi Medical University, Nanning, China.
  • Li X; Key Laboratory of Biological Molecular Medicine Research, Education Department of Guangxi Zhuang Autonomous Region, Guangxi Medical University, Nanning, China.
  • Zhang Y; Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China.
  • He L; Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Nanning, China.
  • Lu Q; Department of Biochemistry and Molecular Biology, School of Basic Medicine, Guangxi Medical University, Nanning, China.
  • Wang Y; Key Laboratory of Biological Molecular Medicine Research, Education Department of Guangxi Zhuang Autonomous Region, Guangxi Medical University, Nanning, China.
  • Pan L; Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China.
  • Wang Z; Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Nanning, China.
  • Feng C; Department of Biochemistry and Molecular Biology, School of Basic Medicine, Guangxi Medical University, Nanning, China.
  • Xie Y; Key Laboratory of Biological Molecular Medicine Research, Education Department of Guangxi Zhuang Autonomous Region, Guangxi Medical University, Nanning, China.
  • Lai Z; Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China.
  • Li T; Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Nanning, China.
  • Tang Z; Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China.
  • Wang Q; Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Nanning, China.
  • Wang X; Departments of Urology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Front Genet ; 13: 1057302, 2022.
Article em En | MEDLINE | ID: mdl-36568387
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article